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SUMMARY
Clinical features, complications and results of investigations are analysed in
50 patients diagnosed byjejunal biopsy as having coeliac disease at the Adult
Gastroenterology Unit, Royal Victoria Hospital, Belfast, between 1969 and
1983. Only one patient was entirely asymptomatic, but 22% had no disturb-
ance of bowel habit, and 50% had not lost weight. There were relatively few
physical abnormalities on clinical examination. Screening tests using standard
haematological and biochemical methods werepositive only in between 8% and
52% ofpatients. More specific tests for malabsorption were positive in between
54% and 84% ofpatients. Jejunal biopsy remains the definitive procedure to
identify patients with coeliac disease.
INTRODUCTION
Only in the past 30 years has 'idiopathic steatorrhoea' or 'non-tropical sprue'
been accepted to be the adult variety of coeliac disease. The gluten-free diet was
first used to treat adults with this condition in 1952,1 and it is current practice that
this dietary modification is recommended 'for life' to ensure continued clinical
remission. It is clearly vital, therefore, that an accurate diagnosis ofthe disorder is
made. Crosby capsule biopsy of the jejunum combined with an assessment of
clinical and histological response to gluten withdrawal has become accepted as
the essential approach to diagnosis. The clinical features which warrant this
procedure and the role of screening blood tests and dynamic studies of
absorptive function are not so well defined.
We have examined the case records of 50 consecutive patients diagnosed as
having coeliac disease in the Adult Gastroenterology Unit, Royal Victoria
Hospital, Belfast, between 1969 and 1983. We describe the presenting
symptoms and signs of these patients and the results of their initial screening
investigations.
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METHODS
A retrospective survey in the Medical Records Department, Royal Victoria
Hospital, Belfast, identified 50 patients who were investigated and diagnosed as
having coeliac disease in the Gastroenterology Unit of that hospital between
1969 and 1983.
Patients were accepted into the study if they had histological evidence of severe
partial villous atrophy or subtotal villous atrophy on jejunal biopsy and if a good
clinical response to gluten withdrawal had been observed. For each patient,
details of presenting symptoms and signs, screening blood tests and malabsorp-
tion studies were recorded. Body weight at presentation and at outpatient review
after institution of the gluten-free diet was also noted. Complicating illness or
associated disease in these patients were documented.
Interpretation of tests for malabsorption
An abnormal faecal fat collection was recorded if a patient excreted more than 5g
fat daily over a three-day period while on a 50g fat diet. In the fat breath test,
breath radioactivitywas measured atfive, six and seven hours after administration
of an oral dose of 5 pCi C14-labelled glyceryl tripalmitate, and fat malabsorption
was diagnosed if the maximum concentration of 14C per millimole CO2 in expired
air was less than 20 x 10-14%. The D-xylose test was performed with a 25g dose
in eight patients, and impaired xylose absorption was recorded if less than 17 %
of the oral dose was collected in a five-hour urine collection; a 5g dose was used
in 33 patients and absorption considered to be impaired if less than 23% of the
oral dose was collected in a five-hour urine collection. A glucose tolerance test
was reported as showing a flat response due to malabsorption if the maximum
blood glucose rise after a 50g oral dose was less than 2.2 mmol/l.
RESULTS
The age of patients at presentation to hospital for assessment was widely varied.
There were 16 men whose ages ranged from 15 to 57 years (median, 30 years)
and 34 women whose ages ranged from 13 to 71 years (median, 30 years). Initial
body weight recordings for the men ranged between 48 and 85 kg, while the
women at presentation weiahed between 26 and 61 kg. A value for body weiqht
was recorded at outpatient review
between four and 12 months after
commencement of the gluten-free
diet in 45 of the patients. The men
showed a mean weight gain of 7.2
kg and the women a gain of 6.6 kg.
Symptoms and clinical signs in all
50 patients at initial presentation
are summarised in Tables I and 11.
Results of haematological and bio-
chemical screening blood tests are
illustrated in Tables Ill and IV. The
spectrum of initial blood haemo-
globin values and red cell mean
corpuscular volume values in men
and women are illustrated in the
Figure.
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Figure. Haemoglobin and red cell mean corpuscular
volume in men and women with coeliac disease.
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TABLE I
Presenting symptoms in.50 coeliac patients
% men % women % Symptom (n = 16) (n = 34) overall
Weight loss 56 47 50
Diarrhoea 75 74 74
Steatorrhoea 38 50 46
Tiredness 38 47 44
Abdominal pain 50 38 42
Carpopedal spasm 6 18 14
Abdominal fullness 12 9 10
Vomiting 0 12 8
Constipation 0 6 4
Bone pain 0 6 4
TABLE II
Presenting signs in 50 coeliac patients
% men % women % Signs (n = 16) (n = 34) overall
Skin pallor 31 35 34
Glossitis 12 18 16
Muscle wasting 12 6 8
Mouth ulcers 12 18 16
Peripheral oedema 0 9 6
Dermatitis herpetiformis 6 3 4
None 63 32 42
TABLE III
Haematology investigations at presentation
Abnormal Abnormal Abnormal
Abnormal men women overall
value (n= 16) (n=34) (n=50)
Haemoglobin <12 g/dl 38 44 42
Mean corpuscular <84 fl 38 9 18
volume >100 fl 0 21 14
Folic acid <2.0 pg/I 44 35 38
Vitamin B12 <200 ng/l 13 21 18
Iron- men <16 pmol/l 44 -
women <11 pmol/I 38
Total iron
binding capacity >70 pmol/l 31 32 32
Prothrombin time >15 seconds 25 18 20
ESR > 10mm/1sthour 25 47 40
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TABLE IV
Blood biochemistry tests at presentation
Number Abnormal Number %
measured value abnormal abnormal
Ca2+ 50 < 2.20 mmol/l 26 52
Mg2+ 18 <0.70 mmol/l 3 17
Zn2+ 12 <8.4 pmol/I 1 8
Albumin 48 <30 g/l 5 10
<35 g/l 13 27
ALT 9 >45 i.u. 3 33
Results of malabsorption tests are summarised in Table V. Only eight patients
received a 25g dose of D-xylose and, ofthese, six had an abnormal result. Ofthe
33 patients who were given a 5g dose of D-xylose, 16 had an abnormally low
urinary excretion.
TABLE V
Malabsorption tests at presentation
Serum carotene
Faecal fats
C'4 fat breath test
D-xylose test
Glucose tolerance test
Urinary indican
Small bowel series
Number Abnormal
measured value
30 <1.1 pmol/l
8 >5g/day
29 *Max value < 20.0
41 <23% 5g
<17% 25g
31 blood sugar rise
<2.2 mmol/l
29 >220 pmol/24 hour
37 'malabsorption picture'
Number %
abnormal abnormal
21 70
6 75
24 83
22 54
26 84
17 59
29 78
At the time of diagnosis of coeliac disease, two patients, one man and one
woman, were found to have dermatitis herpetiformis. This condition developed
subsequently in two other women eight and nine years after the detection of
coeliac disease. Only one patient, a woman, developed a lymphoma, and this
affected the larynx rather than the gastro-intestinal tract. The lymphoma was
detected five years after the diagnosis of coeliac disease. One woman, who had
unequivocal subtotal villous atrophy on jejunal biopsy, and who responded well
to gluten withdrawal, developed hyperparathyroidism and then jejunal Crohn's
disease eight years after coeliac disease had been diagnosed. Three patients had
evidence of pancreatic exocrine insufficiency suggested by an abnormal PABA
test (para-amino benzoic acid absorption). All three had persisting or recurrent
gastro-intestinal symptoms.
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A repeat jejunal biopsy after gluten withdrawal in adult patients with coeliac
disease was not routine clinical practice during most ofthe period covered by our
survey. Seventeen of our patients were re-biopsied recently, between one and 15
years after gluten was excluded from the diet. Thirteen patients were entirely
asymptomatic, three had occasional abdominal cramps and diarrhoea, and one
patient had a severe clinical relapse with weight loss and marked diarrhoea. The
repeat jejunal biopsies were entirely normal only in six patients, and mild villous
atrophy was seen in 10 patients. The patient with severe clinical relapse had
subtotal villous atrophy and responded well to treatment with oral prednisolone.
A careful dietary history taken at the time of repeat biopsy revealed that 44% of
these patients continued, often unknowingly, to consume small amounts of
gluten. The patient with clinical relapse appeared to be adhering strictly to a
gluten-free diet.
DISCUSSION
The wide spectrum of clinical findings in adult patients with untreated coeliac
disease has been illustrated in this study. However, it is likely that our data under-
estimate the number of asymptomatic or mildly symptomatic individuals, since
these people maynot present themselves for investigation. Ifscreeningoffamilies
of coeliac patients became accepted clinical practice, it is possible that an even
higher number of asymptomatic individuals would be identified.
Increasing awareness of the malabsorption disorders and increasing use of
screening biochemical and haematological tests by hospital physicians and
general practitioners might be expected to increase the detection of mild cases of
coeliac disease. Only one of our patients was completely asymptomatic, although
22 % had no disturbance of bowel habit. A higher incidence of diarrhoea was
observed in some of the earlier studies (97% of patients in one report2) although
the classic paper of Cooke and colleagues in 1953 described diarrhoea in only
80% of 100 patients with idiopathic steatorrhoea.3
Weight loss is regarded by many as a cardinal feature of the malabsorption
syndrome and yet this symptom was only recorded in 50% of our patients. Minor
degrees of weight loss may not have been noted by some individuals. Many adult
patients are likely to have been malabsorbing to some extent for long periods of
time before the hospital assessment, and a failure to maintain adequate weight
rather than weight loss may have been a feature oftheir illness. Earlier retrospect-
ive surveys of symptoms in coeliac patients recorded weight loss as a feature in
97-100% of patients.2 3
An important symptom in many of our patients was abdominal pain or fullness.
An erroneous diagnosis of irritable bowel syndrome may be suggested by these
findings unless malabsorption is given due consideration. The more specific
symptom of tetany was observed in only 14% of patients in contrast to 38-50%
of patients in earlier studies.2 3
Abnormal findings on physical examination were detected infrequently in our
survey. It is surprising that no patient was recorded to have finger clubbing or
abnormal pigmentation as these signs have been well documented in severe
coeliac disease.3 Earlier presentation to hospital for diagnosis in recent years may
have influenced the development of signs normally associated with severe long-
standing disease, but it is also possible that subtle alterations in skin pigmentation
or mild clubbing were overlooked or not recorded by the admitting physicians.
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Screening blood tests frequently raise the suspicion of malabsorption. A low
blood haemoglobin level was found in only 42% of our patients, which illustrates
the danger in relying on such tests to exclude the presence of malabsorption.
Cooke and Holmes4 also detected a haemoglobin level of <12 g/dl in 42% of
170 coeliac patients in England, although an Australian survey described
anaemia in 70% of patients.5 A macrocytic blood picture was detected in only
14% of our study group. Folate deficiency is the commonest cause and a serum
folate level of <2.0 pg/l was found in 38% of patients. The absence of macro-
cytosis in some of these individuals was probably related to coexistent iron
deficiency. Hallert and colleagues6 noted low serum folate levels in 85% of
coeliac patients and found a high yield of coeliac disease when patients with
unexplained low folate levels were subjected to jejunal biopsy. Vitamin B12
deficiency is a less frequent abnormality as this is normally absorbed in the
terminal ileum which usually remains free of mucosal damage. Of our patients
18% had a low serum B12 level, but in some ofthese individuals fast small bowel
transit rather than terminal ileal damage may have produced impaired absorption
of this vitamin. Only 18% of our patients had a microcytic blood picture but this
finding was more common in males. The explanation for the difference between
males and females is not clear. Iron deficiency was suggested by a low serum iron
in over 40%, and by a high total iron binding capacity in 32% of the group.
Associated folate or B12 deficiency may have prevented the development of
microcytosis in some of these individuals.
With regard to the blood biochemistry tests, hypoalbuminaemia reflects impaired
protein synthesis and, in some cases, protein loss into the gastro-intestinal tract.
Early reports described thisfinding in over50% ofpatients withcoeliac disease,2 7
although a recent survey had detected serum albumin levels of <40 g/l in 28%
and <30 g/l in only 4% of patients.4 Our findings are fairly similar, 27 % of
patients having a serum albumin <35 g/l and 10% a level <30 g/l. Hypo-
calcaemia might simply reflect the low serum albumin concentration, but 52% of
our patients had low serum calcium levels - a higher percentage than had hypo-
albuminaemia. When the serum calcium level was corrected for the serum
albumin level only 3 of the abnormal results became normal, so it is likely that
most hypocalcaemia was due to true calcium or vitamin D deficiency as part of
the malabsorption syndrome.
Several investigations aid definition of the type of malabsorptive disorder and
some ofthese have been regarded as valuable screening tests for coeliac disease.
The D-xylose test assesses passive absorption of a non-digestible sugar across
the small bowel mucosa. Abnormal results were recorded in over 90% ofpatients
in two surveys,8 9 but other investigators have questioned its value.10 11 In our
survey, only 54% of patients had an abnormal D*xylose excretion. Most received
a 5g load ofxylose, but of those eight patients who were given 25g xylose, 75%
had abnormal results. Rinaldo and Gluckman (1964) also found that a 5g load of
D-xylose was less efficient than the 25g dose at detecting coeliac disease.'2
Clearly, reliance on the D-xylose test as a screening test to exclude malabsorption
syndrome is misplaced and normal results with this investigation should not deter
a clinician from proceeding tojejunal biopsy. Although 84% ofpatients had a flat
glucose tolerance test, thevalueofthis investigation ishindered bythe occurrence
of a flat response in a significant proportion of the normal population.13
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Steatorrhoea is a classical feature of coeliac disease and several investigations
give useful information regarding fat absorption. The traditional three-day
collection of faeces for fat content was carried out in only eight patients and 75%
of these had abnormal results. Fat breath tests measure the radioactivity of
expired air after ingestion of a triglyceride labelled with 14C. Tripalmitate has been
used in the Royal Victoria Hospital with satisfactory results for some years,14
although American investigators found that the 14C triolein breath test provided
more reliable discrimination, mainly due to greater specificity.15 Of 29 patients in
our study who had a tripalmitate breath test 83% had an abnormal result, which
isnot sufficiently sensitive toallow accurate selection of patients forjejunal biopsy.
Our observations have highlighted the clinical features of coeliac patients in adult
gastroenterological practice in Northern Ireland. It appears that milder forms of
the disease are being recognised than was the case in the 1950s when the
condition was first defined. The presence of severe villous atrophy is rarely seen
in conditions other than coeliac disease in adult patients, although this is not the
case with children. In clinical practice a more difficult group to classify are those
adult patients whosejejunal biopsies show only mild or moderate villous atrophy,
findings which can be caused by many disorders. Some of these individuals were
encountered in our survey, and although they had been treated by gluten
withdrawal, they were not included in this analysis. Similarly, there were two or
three individuals who were treated by gluten withdrawal, but for whom no
histological confirmation of the diagnosis of coeliac disease was made because of
technical failure of the Crosby capsule biopsy instrument. A repeatjejunal biopsy
after gluten withdrawal followed by a period of gluten challenge and further
biopsy would be of particular value in the assessment of these groups of patients
whose diagnosis is less well established, before lifelong gluten avoidance is
imposed.
A wide spectrum of haematological and biochemical disturbances may occur in
coeliac patients but no single test offers a reliable method of screening for the
condition. Tests of absorptive function have failed to identify sufficient patients to
serve as reliable screening tests for coeliac disease. Better screening tests are
required so that milder forms of the condition may be identified. Serum anti-
gliadin antibody determination'6 and release of N-terminal glucagon'7 have been
proposed as possible screening tests but further assessment of their sensitivity in
adult patients is required. The former reflects the immunological response to
gliadin, which is thought to be the toxic component of gluten, and abnormal
levels have been found in about 90% of coeliac patients. 16Release of N-terminal
glucagon probably reflects increased stimulation of the distal ileum by food which
is malabsorbed in the jejunum.'7 Thus, elevated plasma levels of this hormone
are not specific to coeliac disease and are encountered in a variety of conditions
associated with small bowel malabsorption. Jejunal biopsy with a Crosby capsule
remains the definitive investigation to identify patients with coeliac disease. This
procedure can be performed rapidly and without significant discomfort during
upper endoscopic examination,'8 and should be undertaken when the diagnosis
of coeliac disease is considered.
We are indebted to our predecessors in the Gastroenterology Unit, Royal Victoria Hospital, whose
careful documentation of their coeliac patients made our survey possible.
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